1. Investigation of the Antarctic krill tripeptide Phe-Pro-Phe (FPF) for its antioxidant properties and mechanism
    Jingqi Yang et al, 2024, Food Bioscience CrossRef
  2. Luteolin, a Potent Anticancer Compound: From Chemistry to Cellular Interactions and Synergetic Perspectives
    Hardeep Singh Tuli et al, 2022, Cancers CrossRef
  3. Natural flavonoids for the prevention of colon cancer: A comprehensive review of preclinical and clinical studies
    Khashayar Afshari et al, 2019, Journal of Cellular Physiology CrossRef
  4. Doxorubicin hydrochloride enhanced antitumour effect of CEA‐regulated oncolytic virotherapy in live cancer cells and a mouse model
    Boduan Xiao et al, 2020, Journal of Cellular and Molecular Medicine CrossRef
  5. The Role of TRAIL Signaling in Cancer: Searching for New Therapeutic Strategies
    Cheng Luo et al, 2024, Biology CrossRef
  6. Anticancer activity of the plant flavonoid luteolin against preclinical models of various cancers and insights on different signalling mechanisms modulated
    Shabir Ahmad Ganai et al, 2021, Phytotherapy Research CrossRef
  7. Natural product-based radiopharmaceuticals: Focus on curcumin and its analogs, flavonoids, and marine peptides
    Hendris Wongso, 2022, Journal of Pharmaceutical Analysis CrossRef
  8. Oncolytic Adenovirus CD55-Smad4 Suppresses Cell Proliferation, Metastasis, and Tumor Stemness in Colorectal Cancer by Regulating Wnt/β-Catenin Signaling Pathway
    Boduan Xiao et al, 2020, Biomedicines CrossRef
  9. Immuno-Oncolytic Viruses: Emerging Options in the Treatment of Colorectal Cancer
    Sadia Islam Kana et al, 2021, Molecular Diagnosis & Therapy CrossRef
  10. Phenolic Phytochemicals for Prevention and Treatment of Colorectal Cancer: A Critical Evaluation of In Vivo Studies
    Samhita De et al, 2023, Cancers CrossRef
  11. Cancer Chemoprevention by Dietary Polyphenols, Flavonoids, Terpenoids, and Saponins
    Rahul L. Gajbhiye et al, 2019, Bioactive Natural Products for the Management of Cancer: from Bench to Bedside CrossRef
  12. Oncolytic adenovirus carrying SPAG9-shRNA enhanced the efficacy of docetaxel for advanced prostate cancer
    Meng Lu et al, 2022, Anti-Cancer Drugs CrossRef
  13. The dietary flavone luteolin epigenetically activates the Nrf2 pathway and blocks cell transformation in human colorectal cancer HCT116 cells
    Qian Zuo et al, 2018, Journal of Cellular Biochemistry CrossRef
  14. Luteolin enhances the antitumor efficacy of oncolytic vaccinia virus that harbors IL‐24 gene in liver cancer cells
    Chunming Wang et al, 2021, Journal of Clinical Laboratory Analysis CrossRef
  15. Luteolin mediated targeting of protein network and microRNAs in different cancers: Focus on JAK-STAT, NOTCH, mTOR and TRAIL-mediated signaling pathways
    Ammad Ahmad Farooqi et al, 2020, Pharmacological Research CrossRef
  16. Insight into the structure, function and the tumor suppression effect of gasdermin E
    Yuge Long et al, 2024, Biochemical Pharmacology CrossRef
  17. Oncolytic viruses combined with immune checkpoint therapy for colorectal cancer is a promising treatment option
    Yi Ren et al, 2022, Frontiers in Immunology CrossRef
  18. Viral therapy for targeted drug delivery to cancers: Recent advances, clinical and regulatory perspectives
    Kanaka Dhuri et al, 2024, Journal of Drug Delivery Science and Technology CrossRef
  19. Oncolytic adenovirus encoding LHPP exerts potent antitumor effect in lung cancer
    Yaru Zhao et al, 2024, Scientific Reports CrossRef
  20. Immunotherapy for colorectal cancer: Rational strategies and novel therapeutic progress
    Farangis Rastin et al, 2024, International Immunopharmacology CrossRef